Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Clinical significance of nm23-H1 proteins expressed on cell surface in non-Hodgkin's lymphoma

Leukemia volume 17, pages 196–202 (2003)Cite this article

Abstract

The nm23 gene was isolated as a metastasis suppressor gene that exhibits low expression in high-level metastatic cancer cells. Its gene is related to the prognosis of acute myelogenous leukemia (AML) and non-Hodgkin's lymphoma (NHL). In this study, we examined the expression of nm23-H1 protein on the lymphoma cell surface of NHL. In 28 of 108 cases (25.9%), we observed ≥20% of cell surface nm23-H1 protein expression and expression was especially high in peripheral T cell lymphomas and extranodal NK/T cell lymphomas. We also observed a significant correlation between serum nm23-H1 level and cell surface nm23-H1 expression levels. In patients with high levels of cell surface nm23-H1 expression, overall and progression-free survival rates were significantly lower than those in patients with low surface nm23-H1 expression levels. When surface nm23-H1 and serum nm23-H1 were combined, patients with high levels of both exhibited a poorer prognosis than patients with a high level of one or the other. These results indicate that in addition to serum nm23-H1, cell surface nm23-H1 may be used as a prognostic factor in planning a treatment strategy. The nm23-H1 protein appears to be intimately related to biological aggressiveness of lymphoma and, therefore, might be a molecular target of NHL treatment.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Steeg, PS, Bevilacqua, G, Kopper, L, Thorgeirsson, UP, Talmadge, JE, Liotta, LA & Sobel, ME Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst, (1988). 80, 200–204.

    Article  CAS  Google Scholar 

  2. De La Rose, A, Williams, RL & Steeg, PS Nm23/nucleoside diphosphate kinase: toward a structural and biochemical understanding of its biological functions. BioEssays, (1995). 17, 53–62.

    Article  Google Scholar 

  3. Okabe-Kado, J, Kasukabe, T, Honma, Y, Hayashi, M, Henzel, WJ & Hozumi, M Identity of a differentiation inhibiting factor for mouse myeloid leukemia cells with nm23/nucleoside diphosphate kinase. Biochem Biophys Res Commun, (1992). 182, 987–994.

    Article  CAS  Google Scholar 

  4. Okabe-Kado, J, Kasukabe, T, Honma, Y, Hayashi, M & Hozumi, M Purification of a factor inhibiting differentiation from conditioned medium of nondifferentiating mouse myeloid leukemia cells. J Biol Chem, (1988). 263, 10994–10999.

    CAS  PubMed  Google Scholar 

  5. Lacombe, ML, Milon, L, Munier, A, Mehus, JG & Lambeth, DO The human nm23/nucleoside diphosphate kinases. J Bioenerg Biomembr, (2000). 32, 247–258.

    Article  CAS  Google Scholar 

  6. Aryee, DN, Simonitsch, I, Mosberger, I, Kos, K, Mann, G, Schlogl, E, Potschger, U, Gadner, H, Radaszkiewicz, T & Kovar, H Variability of nm23-H1/NDPK-A expression in human lymphomas and its relation to tumor aggressiveness. Br J Cancer, (1996). 74, 1693–1698.

    Article  CAS  Google Scholar 

  7. Niitsu, N, Okabe-Kado, J, Kasukabe, T, Yamamoto-Yamaguchi, Y, Umeda, M & Honma, Y Prognostic implications of the differentiation inhibitory factor nm23-H1 protein in the plasma of aggressive non-Hodgkin's lymphoma. Blood, (1999). 94, 3541–3550.

    CAS  PubMed  Google Scholar 

  8. Niitsu, N, Okabe-Kado, J, Okamoto, M, Takagi, T, Yoshida, T, Aoki, S, Hirano, M & Honma, Y Serum nm23-H1 protein as a prognostic factor in aggressive non-Hodgkin's lymphoma. Blood, (2001). 97, 1202–1210.

    Article  CAS  Google Scholar 

  9. Niitsu, N, Okabe-Kado, J, Nakayama, M, Wakimoto, N, Sakashita, A, Maseki, N, Motoyoshi, K, Umeda, M & Honma, Y Plasma levels of the differentiation inhibitory factor nm23-H1 protein and their clinical implications in acute myelogenous leukemia. Blood, (2000). 96, 1080–1086.

    CAS  PubMed  Google Scholar 

  10. Harris, NL, Jaffe, ES, Stein, H, Banks, PM, Chan, JK, Cleary, ML, Delsol, G, De Wolf-Peeters, C, Falini, B & Gatter, KC A revised European–American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood, (1994). 84, 1361–1392.

    CAS  Google Scholar 

  11. Carbone, PP, Kaplan, HS, Musshoff, K, Smithers, DW & Tubiana, M Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res, (1971). 31, 1860–1861.

    CAS  PubMed  Google Scholar 

  12. Shipp, MA A predictive model for aggressive non-Hodgkin's lymphomas. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med, (1993). 329, 987–994.

    Article  Google Scholar 

  13. Niitsu, N & Umeda, M Biweekly COP-BLAM (cyclophosphamide, vincristine, prednisone, bleomycin, doxorubicin and procarbazine) regimen combined with granulocyte colony stimulating factor (G-CSF) for intermediate-grade non-Hodgkin's lymphoma. Eur J Haematol, (1996). 56, 163–167.

    Article  CAS  Google Scholar 

  14. McKelvey, EM, Gottlieb, JA, Wilson, HE, Haut, A, Talley, RW, Stephens, R, Lane, M, Gamble, JF, Jones, SE, Grozea, PN, Gutterman, J, Coltman, C & Moon, TE Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma. Cancer, (1976). 38, 1484–1493.

    Article  CAS  Google Scholar 

  15. Kaplan, EL & Meier, P Nonparametric estimation from incomplete observations. J Am Stat Assoc, (1958). 53, 457–481.

    Article  Google Scholar 

  16. Wilcoxon, F Individual comparisons by ranking methods. Biometrics Bull, (1945). 1, 80–83.

    Article  Google Scholar 

  17. Mantel, N Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep, (1966). 50, 163–170.

    CAS  Google Scholar 

  18. Stahl, JA, Leone, A, Rosengard, AM, Porter, L, Kin, CR & Steeg, PS Identification of a second human nm23 gene, nm23-H2. Cancer Res, (1991). 51, 445–449.

    CAS  PubMed  Google Scholar 

  19. Backer, JM, Mendra, CE, Kovesdi, I, Fairhurst, JL, O’Hara, B, Eddy, RL, Shows, TB, Methew, S, Murty, VV & Chaganti, RS Chromosomal localization and nucleoside diphosphate kinase activity of human metastasis-suppressor genes NM23-1 and NM23-2. Oncogene, (1993). 8, 497–502.

    CAS  Google Scholar 

  20. Chandrasekharappa, SC, Gross, LA, King, SE & Collins, FS The human NME2 gene lies within 18kb of NME1 in chromosome 17. Genes Chromosomes Cancer, (1993). 6, 245–248.

    Article  CAS  Google Scholar 

  21. Gilles, AM, Presecan, E, Vonica, A & Lascu, I Nucleoside diphosphate kinase from human erythrocytes. J Biol Chem, (1991). 266, 8784–8789.

    CAS  PubMed  Google Scholar 

  22. Leone, A, Seeger, RC, Hong, CM, Hu, YY, Arboleda, MJ, Brodeur, GM, Stram, D, Slamon, DJ & Steeg, PS Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastoma. Oncogene, (1993). 8, 855–865.

    CAS  Google Scholar 

  23. Chang, C, Zhu, X-X, Thoraval, D, Ungar, D, Rawwas, J, Hora, N, Strahler, J, Hanash, S & Radany, E nm23-H1 mutation in neuroblastoma. Nature, (1994). 370, 335–336.

    Article  CAS  Google Scholar 

  24. Yokoyama, A, Okabe-Kado, J, Wakimoto, N, Kobayashi, H, Sakashita, A, Maseki, N, Nakamaki, T, Hino, K, Tomoyasu, S, Tsuruoka, N, Motoyoshi, K, Nagata, N & Honma, Y Evaluation by multivariate analysis of the differentiation inhibitory factor nm23 as a prognostic factor in acute myelogenous leukemia and application to other hematologic malignancies. Blood, (1998). 91, 1845–1851.

    CAS  PubMed  Google Scholar 

  25. Urano, T, Furukawa, K & Shiku, H Expression of nm23/NDP kinase proteins on the cell surface. Oncogene, (1993). 8, 1371–1376.

    CAS  PubMed  Google Scholar 

  26. Willems, R, Van Bockstaele, DR, Landon, F, Lenjou, M, Nijs, G, Snoeck, HW, Berneman, ZN & Slegers, H Decrease in nucleoside diphosphate kinase expression during hematopoietic maturation. J Biol Chem, (1993). 273, 13663–13668.

    Article  Google Scholar 

  27. MacDonald, NJ, de la Rosa, A & Steeg, PS The potential roles of nm23 in cancer metastasis and cellular differentiation. Eur J Cancer, (1995). 31, 1096–1100.

    Article  Google Scholar 

  28. Alizadeh, AA, Eisen, MB, Davis, RE, Ma, C, Lossos, IS, Rosenwald, A, Boldrick, JC, Sabet, H, Tran, T, Yu, X, Powell, JI, Yang, L, Marti, GE, Moore, T, Hudson, J Jr, Lu, L, Lewis, DB, Tibshirani, R, Sherlock, G, Chan, WC, Greiner, TC, Weisenburger, DD, Armitage, JO, Warnke, R & Staudt, LM Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature, (2000). 403, 503–511.

    Article  CAS  Google Scholar 

  29. Aguiar, RT, Yakushijin, Y, Kharbanda, S, Salgia, R, Fletcher, JA & Shipp, MA BAL is a novel risk-related gene in diffuse large B-cell lymphomas that enhances cellular migration. Blood, (2000). 96, 4328–4334.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Supported in part by a grant from the Ministry of Health and Welfare, and Grants-in-Aid for Scientific Research (C) and Cancer Research, from The Ministry of Education, Culture, Sports, Science, and Technology (MEXT) Japan.

Author information

Authors and Affiliations

  1. Department of Hematology and Internal Medicine IV, Kitasato University School of Medicine, Kanagawa, Japan

    N Niitsu & M Higashihara

  2. Saitama Cancer Center Research Institute, Saitama, Japan

    Y Honma & J Okabe-Kado

  3. First Department of Internal Medicine, Toho University School of Medicine, Tokyo, Japan

    K Iijima

  4. Hematology-Oncology Division, Chiba, Cancer Center Hospital, Chiba, Japan

    T Takagi

  5. First Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan

    U Sawada

Authors
  1. N Niitsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Y Honma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K Iijima
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T Takagi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M Higashihara
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. U Sawada
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J Okabe-Kado
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Niitsu, N., Honma, Y., Iijima, K. et al. Clinical significance of nm23-H1 proteins expressed on cell surface in non-Hodgkin's lymphoma. Leukemia 17, 196–202 (2003). https://doi.org/10.1038/sj.leu.2402699

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402699

Keywords

This article is cited by

Search

Advanced search

Quick links